Exclusions

The JLA does not invite representatives of the pharmaceutical industry or those in the research community who are not also clinicians, patients or carers to participate in the priority setting process.

Traditionally the health research agenda has been largely determined by the pharmaceutical industry and researchers themselves. This has usually been with minimal input from patients or patients and clinicians combined.

The JLA exists to address this imbalance.

To find out more about this, click here.